Attached files

file filename
EX-32.1 - EX-32.1 - CHINOOK THERAPEUTICS, INC.kdny-ex321_261.htm
EX-31.2 - EX-31.2 - CHINOOK THERAPEUTICS, INC.kdny-ex312_262.htm
EX-31.1 - EX-31.1 - CHINOOK THERAPEUTICS, INC.kdny-ex311_263.htm
EX-21.1 - EX-21.1 - CHINOOK THERAPEUTICS, INC.kdny-ex211_421.htm
EX-10.23 - EX-10.23 - CHINOOK THERAPEUTICS, INC.kdny-ex1023_981.htm
EX-4.2 - EX-4.2 - CHINOOK THERAPEUTICS, INC.kdny-ex42_265.htm
10-K - 10-K - CHINOOK THERAPEUTICS, INC.kdny-10k_20201231.htm

Exhibit 23.1

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (Nos. 333-203508, 333-210016, 333-216373, 333-223382, 333-229915, 333-237034 and 333-249351) of Chinook Therapeutics, Inc. of our report dated April 7, 2021 relating to the financial statements, which appears in this Form 10-K.

 

 

/s/ PricewaterhouseCoopers LLP

Seattle, Washington

April 7, 2021

 

 

 

1